Close Menu

LDTs

During an FDA-sponsored workshop last week, participants discussed ideas for a regulatory framework that can evolve with rapidly advancing technology.

The committee questioned stakeholders about the impact of FDA oversight of LDTs, and whether there was any consensus about how to move forward on a divisive topic.

The group hopes its proposed regulatory framework might strike a compromise between different industry stakeholders.

Pages